Podcast

James Franciosi, MD, MS, MSCE, on How Genetic Variations Influence PPI Therapy in Pediatric EoE

12/20/2019

 

In this podcast, James Franciosi, MD, MS, MSCE, from Nemours Children’s Hospital, discusses the prevalence of pediatric eosinophilic esophagitis (EoE), his research on how genetic variations can differentiate responses to proton-pump inhibitor therapy in pediatric EoE, and more.

James Franciosi, MD, MS, MSCE, is chief of the Division of Gastroenterology, Hepatology and Nutrition at Nemours Children’s Hospital in Orlando, Florida.

 

Reference:

Mougey EB, Williams A, Coyne AJK, et al. CYP2C19 and STAT6 variants influence the outcome of proton pump inhibitor therapy in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2019;69(5):581-587. doi:10.1097/MPG.0000000000002480.

Related Content

Cardiovascular Diseases
Cardiovascular Diseases
William Boden, MD, on PCI for Preventing Cardiac Events
07/17/2017
Dr William Boden from the VA New England Healthcare System discusses the key takeaways from his session about coronary stenting at the American Society for Preventive Cardiology's 2018 Congress on CVD...
07/17/2017
Pain Management
Pain Management
Molly Jeffery, PhD, on The Stubborn Opioid Epidemic: Change Is Within Reach
08/22/2018
Molly Jeffery, PhD, from the Mayo Clinic, discusses her study on the rates of opioid use in the United States, which have remained largely unchanged over the past decade despite increased awareness...
08/22/2018
Osteoporosis
Osteoporosis
The Association of Atherosclerosis and BMD in Middle-Aged Men
07/04/2022
In this podcast, Akira Sekikawa, MD, PhD, talks about his research on the association of atherosclerosis and bone mineral density in an international cohort of middle-aged men. 
07/04/2022
Prostate Cancer
Prostate Cancer
Nina Karlin, MD, on Whether Diabetes and Prostate Cancer Interact
07/27/2017
Nina Karlin, MD, from the Mayo Clinic in Arizona, discusses her latest research on the interaction between prostate cancer and diabetes.
07/27/2017
Cardiometabolic Risk
Cardiometabolic Risk
James Matera, DO, on Appropriate BP Targets in Kidney Disease
07/19/2020
James Matera, DO, discusses optimal blood pressure targets in patients with kidney disease, and how the 2017 AHA/ACC hypertension guidelines affect these targets.
07/19/2020